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Abstract Epileptogenesis is a process triggered by initial en-
vironmental or genetic factors that result in epilepsy and may
continue during disease progression. Important parts of this
process include changes in transcriptome and the pathological
rewiring of neuronal circuits that involves changes in neuronal
morphology. Mammalian/mechanistic target of rapamycin
(mTOR) is upregulated by proconvulsive drugs, e.g., kainic
acid, and is needed for progression of epileptogenesis, but
molecular aspects of its contribution are not fully understood.
Since mTOR can modulate transcription, we tested if
rapamycin, an mTOR complex 1 inhibitor, affects kainic
acid-evoked transcriptome changes. Using microarray tech-
nology, we showed that rapamycin inhibits the kainic
acid-induced expression of multiple functionally heteroge-
neous genes. We further focused on engulfment and cell mo-
tility 1 (Elmo1), which is a modulator of actin dynamics and
therefore could contribute to pathological rewiring of neuronal
circuits during epileptogenesis. We showed that prolonged
overexpression of Elmo1 in cultured hippocampal neurons
increased axonal growth, decreased dendritic spine density,
and affected their shape. In conclusion, data presented herein
show that increased mTORC1 activity in response to kainic
acid has no global effect on gene expression. Instead, our
findings suggest that mTORC1 inhibition may affect develop-
ment of epilepsy, by modulating expression of specific subset
of genes, including Elmo1, and point to a potential role for
Elmo1 in morphological changes that accompany
epileptogenesis.
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Introduction
Epilepsy is a common chronic neurological disorder that is
characterized by recurrent seizures that are unpredictable and
sometimes progressively severe [1]. Epilepsy is triggered by
various environmental and genetic factors [2, 3] that induce
numerous molecular changes, including changes in gene ex-
pression, that drive epileptogenesis [4, 5]. An important part
of epileptogenesis is the pathological rewiring of neuronal
circuits that involves changes in neuronal morphology (e.g.,
dendritic spine rearrangement and axonal sprouting; [6, 7]).
Several lines of evidence suggest links between
epileptogenesis and complex 1 of mammalian/mechanistic
target of rapamycin (mTOR), a serine-threonine protein kinase
[8, 9]. On one hand, status epilepticus induces mTOR activa-
tion [10–13]. On the other hand, rapamycin, an mTOR inhib-
itor, has antiepileptogenic effects in kainic acid (KA)-induced
and pilocarpine-induced models of epilepsy in animals
[13–15]. Among other cellular roles, mTOR complex 1
(mTORC1) is known to control the transcription of several
genes [16]. Our previous studies found increased nuclear
levels of phosphorylated mTOR in hippocampal and cortical
neurons cultured in vitro and in the brain in vivo after
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application of KA [11]. This observation could suggest that
mTOR contributes to epileptogenesis by regulating gene ex-
pression. To test this hypothesis, in the present study, we
aimed to evaluate effects of rapamycin on KA-evoked tran-
scriptome changes in organotypic hippocampal slices using a
microarray technology. The analysis revealed that mTORC1
is not a major driving force behind transcriptome changes
induced by KA. Nevertheless, we found effects of rapamycin
on the KA-induced expression of multiple functionally het-
erogeneous genes. One of them was engulfment and cell mo-
tility 1 (Elmo1), which duration of KA-induced expression
was inhibited by rapamycin.
Elmo1, in complex with RhoG and Dock180, induces the
activation of small GTPase Rac1 [17], a major regulator of
actin dynamics [18]. Reorganized F-actin networks have been
postulated to lead to the long-term stabilization of synaptic
changes and consolidation of enhanced neuronal activity.
Thus, alterations in F-actin network may be related to the
aberrant hyperexcitability that is observed in epilepsy [19].
Rac1 and RhoA were significantly upregulated in the
pentylenetetrazole kindling model and play a role in aberrant
mossy fiber sprouting [20]. Links between Rac and epilepsy
were further revealed by the impairment of hippocampal cir-
cuitry and epileptic phenotype of Rac1/Rac3 double-knockout
mice [21]. Nonetheless, however, the role of Rho-family small
GTPases and actin reorganization in epilepsy is poorly under-
stood and the role of Elmo1 in epilepsy has not yet been
elucidated. Thus, in the second part of this study, we investi-
gated in more details effects of prolonged overexpression of
Elmo1 in cultured hippocampal neurons and showed in-
creased axonal growth, decreased dendritic spine density,
and affected their shape.
Materials and Methods
Antibodies and Reagents
The antibodies that were used in the study are listed in Table 1.
The following reagents were used for pharmacological treat-
ments: dimethylsulfoxide (DMSO; Sigma-Aldrich, St. Louis,
MO, USA), rapamycin (R; LC Laboratories, Woburn, MA,
USA), and kainic acid (KA, Tocris Bioscience, Ellisville,
MO, USA). Hoechst 33342 was purchased from Life
Technologies (Carlsbad, CA, USA).
DNA Constructs
The mammalian expression plasmids β-actin-green fluores-
cent protein (GFP) and pSuper have been described previous-
ly [22, 23]. β-Actin-tdTomato plasmid, which encodes
tdTomato under control of the β-actin promoter, was obtained
by subcloning the tdTomato coding sequence using EcoRI/
B amH I [ 2 4 ] t o mod i f i e d β - a c t i n - 1 6 p l [ 2 5 ] .
β-Actin-Elmo1-GFP was obtained by subcloning the rat
Elmo1 coding sequence to EcoRI/SalI sites of β-actin-GFP.
The coding sequence of Elmo1 was obtained from rat neuro-
nal complementary DNA (cDNA) by polymerase chain reac-
tion (PCR) using the following primers: 5′-GAGAATT
CGTAATGCAGGTGGTGAAG-3′ and 5′-TGGTCGAC
TCAGTTACAGTCATAAACA-3′. pSuper-sh#Elmo1 was
obtained by subcloning the previously described Elmo1 short
hairpin RNA (shRNA) coding sequence [26] to pSuper.
Organotypic Hippocampal Slices
Hippocampal slice cultures were prepared based on the meth-
od described by Stoppini et al. [27] and in conformity with
institutional guidelines of the First Local Ethics Committee in
Warsaw (decision no. 861/2007), which are in compliance
with the European Community Council Directive (86/609/
EEC). Briefly, 8- to 10-day-old Wistar rat pups were decapi-
tated without anesthesia and the hippocampi were dissected.
Sections (400 μm) were prepared using a McIlwain tissue
chopper (Ted Pella, Redding, CA, USA) and separated under
ice-cold Gey’s balanced salt solution (Sigma-Aldrich; supple-
mented with 5 mg/ml glucose and 1 % penicillin/streptomy-
cin). Slices were plated on semiporous membranes (four per
membrane; Millipore, Darmstadt, Germany) and maintained
at 37 °C in 5 % CO2 in Minimum Essential Medium (MEM)
supplemented with Earle’s salts (MP Biomedicals, Santa Ana,
CA, USA) and 25 % Hanks’ balanced salt solution (HBSS;
MP Biomedicals), 25 % heat-inactivated horse serum
(Sigma-Aldrich), 5 mg/ml glucose, 1 mM glutamine, and
1 % penicillin/streptomycin (all from Sigma-Aldrich). The
maintenance media was changed every 3–4 days. For pharma-
cological treatments, slices on day 5 in vitro (DIV5) were treat-
ed either with vehicle (DMSO) or 10 μM KA (Fig. 1a). To
inhibit mTOR activity, 20 nM rapamycin was added to slices
either alone or in combination with KA (Fig. 1a). Rapamycin
was added 2 h prior to KA. Slices were collected 0.5, 2, 6, and
24 h after KA treatment (Fig. 1a). For the analysis of aberrant
axonal sprouting, DIV10 slices were treated with 6 μMKA for
48 h. Rapamycin was added 2 h prior to KA and present during
KA treatment. The medium was then changed to maintenance
medium, and slices were cultured until DIV26.
Animals and Pharmacological Treatment
For the pharmacological experiments, 3-month-old male
Wistar rats were used and described procedures were con-
ducted in conformity with the institutional guidelines of
the First Local Ethics Committee in Warsaw (decision no.
76/2010), which are in compliance with the European
Community Council Directive (86/609/EEC). Tissue for
messenger RNA (mRNA) analysis was collected during
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experiments described by Macias et al. [11]. Briefly, the
animals were divided into four groups: vehicle, KA,
rapamycin, and rapamycin+KA. Rapamycin was initially
dissolved in 100 % ethanol for long-term storage. Prior to
the injection, rapamycin was diluted in a vehicle solution
that contained 5 % Tween 80 and 5 % PEG 400
(low-molecular-weight grade of polyethylene glycol;
Sigma) and injected intraperitoneally (i.p.; 10 mg/kg)
three times per week for 4 weeks. A control group of rats
was injected with vehicle solution (5 % Tween 80, 5 %
PEG 400, and 4 % ethanol). KA (10 mg/kg) was delivered
by i.p. injection. In the rapamycin+KA group, KA was
injected 48 h after the last dose of rapamycin.
KA-injected animals were observed, and their behavior
was digitally recorded. Severity of seizures was assessed
according to a modified Racine’s scale [28]. Only the
animals that displayed three episodes of generalized sei-
zures (stage 3) were further analyzed. The rats were
sacrificed 2 h following KA injection. Next, cortices and
hippocampi were dissected from the brains and stored in
RNAlater (Life Technology, Carlsbad, CA, USA)
in −80 °C until use.
Primary Hippocampal and Cortical Neuron Cultures,
Transfection, and Pharmacological Treatment
Animals that were used to obtain neurons for cell culture were
sacrificed according to the protocol approved by the First
Ethical Committee in Warsaw, Poland (decision no. 76/
2010). Primary hippocampal and cortical cultures were pre-
pared from embryonic day 19 (E19) rat brains as described
previously [29]. Cells were plated on coverslips coated with
poly-L-lysine (37.5 μg/ml, Sigma-Aldrich) and laminin
(2.5 μg/ml, Roche, Basel, Switzerland) at a density of 500
cells/mm2 (hippocampal) or precoated BioCoat plastic plates
(BD Biosciences Discovery Labware, San Jose, CA, USA) at
Table 1 Antibodies used in the study
Primary antibody Host Manufacturer; catalog no.; dilution Secondary antibody
Enhanced chemiluminescent (ECL) detection
Anti-phospho-S6 (P-S6) Ser235/
236
Rabbit Cell Signaling Technology, Beverly,
MA; #4858; 1:500 in 5 % BSA in TBS-Ta
Anti-rabbit IgG, HRP-conjugated; Cell
Signaling Technology, Beverly, MA; #7074;
1:10000 in 5 % nonfat milk in TBS-TAnti-S6 (S6) Rabbit Cell Signaling Technology, Beverly,
MA; #2217; 1:1000 in 5 % BSA in TBS-T
Anti-mTOR Rabbit Cell Signaling Technology, Beverly,
MA; #2983; 1:1000 in 5 % BSA in TBS-T
Anti-caspase-3 Rabbit Cell Signaling Technology, Beverly,
MA; #9662; 1:1000 in 5 % BSA in TBS-T
Anti-GFP Rabbit MBL International Corporation,
Geel, Belgium; #598; 1:2000 in 5 %
nonfat dry milk in TBS-T
Anti-Elmo1 Rabbit Eurogentec, Liege, Belgium; custom orderb;
1:500 in 5 % nonfat dry milk in TBS-T
Anti-α-tubulin Mouse Sigma-Aldrich, St. Louis, MO; #T5168;
1:20,000 in 5 % nonfat dry milk in TBS-T
Anti-mouse IgG, HRP-conjugated; Cell
Signaling Technology, Beverly, MA; #7076;
1:10000 in 5 % nonfat milk in TBS-T
Anti-β-actin-HRP Mouse Sigma-Aldrich, St. Louis, MO; A3854;





Rabbit Cell Signaling Technology, Beverly,
MA; #4858; 1:200 in 1 % donkey
serum in PBS-Tc
Anti-rabbit IgG Alexa Fluor 488; Life
Technologies, Carlsbad, CA; A-21206;
1:500 in 1 % donkey serum in PBS-T
Anti-c-Fos Rabbit Santa Cruz Biotechnology, Santa Cruz,
CA; #7202; 1:200 in 1 % donkey serum in PBS-T
Anti-GFAP Mouse Millipore, Darmstadt, Germany;
#04-1031; 1:500 in 1 % donkey serum in PBS-T
Anti-GFP Mouse MBL International Corporation, Geel,
Belgium; #598; 1:1000 in GDB bufferd
a Tris-buffered saline (TBS-T) (50 mM Tris, 150 mM NaCl), pH 7.6 + 0.1 % Tween 20
b Elmo1 peptide sequence taken for rabbit immunization: aa 109–124: GDLEESPQGEVPHDSL
c Phosphate-buffered saline (PBS-T) (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4), pH 7.4 + 0.2 % Triton X-100
dGDB buffer (0.2 % gelatin, 0.8 M NaCl, 0.5 % Triton X-100, 30 mM phosphate buffer), pH 7.4)
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a density of 1250/mm2 (cortical). Neuronal cultures were
grown in Neurobasal medium (Life Technologies) supple-
mented with B27 (Life Technologies), 0.5 mM glutamine,
12.5 μM glutamate, and penicillin/streptomycin mix (all from
Sigma-Aldrich). For the morphology experiments on day
in vitro (DIV) 1, 8, or 18 hippocampal cultures were
transfected using Lipofectamine2000 (Life Technologies) for
3 days as described previously [30]. In the overexpression
experiments, β-actin-GFP or β-actin-Elmo1-GFP was
cotransfected with β-actin-tdTomato at a 3:1 ratio. To visual-
ize dendritic protrusions, the cells were stained with GFP tags.
To characterize anti-Elmo1 antibody, cortical cultures were
transfected on DIV0 using an Amaxa Nucleofector II Device
and Amaxa Rat Neuron Nucleofactor Kit (Lonza, Basel,
Switzerland) according to a modification of the manufac-
turer’s protocol [31] with pSuper or pSuper-sh#Elmo1 and
β-actin-GFP or β-actin-Elmo1-GFP. Four days later, the cells
were lysed.
For pharmacological treatments on DIV14, cortical cul-
tures were treated with either vehicle (DMSO, control) or
25 μM KA for 10 min. To inhibit mTOR activity, 20 nM
rapamycin was added to the cultures either alone or in combi-
nation with KA. Cortical cultures were collected 4 and 24 h
after KA treatment and then lysed in sodium dodecyl sulfate
(SDS) sample buffer forWestern blot analysis or RNAlater for
reverse-transcription quantitative real-time polymerase chain
reaction (qRT-PCR) analysis.
Immunofluorescent Labeling
For the immunofluorescent staining of overexpressed pro-
teins, neurons were fixed with 4 % paraformaldehyde (PFA)
that contained 4% sucrose in phosphate-buffered saline (PBS)
for 10 min at room temperature. After fixation, the cells were
washed three times with PBS for 5 min at room temperature
and incubated with primary antibodies in GDB buffer (0.2 %
gelatin, 0.8 M NaCl, 0.5 % Triton X-100, and 30 mM phos-
phate buffer, pH 7.4) overnight at 4 °C. The cells were then
washed three times with PBS for 10 min at room temperature.
Secondary antibodies were applied in GDB for 1 h at room
temperature and underwent three washes with PBS, 10 min
each. Secondary antibodies that were conjugated to Alexa
Fluor 488 were used for labeling.
For immunofluorescent staining, organotypic slices were
fixed with 4 % PFA that contained 4 % sucrose in PBS for
24 h at 4 °C. The slices were then washed with PBS that
contained 0.2 % Triton-X100 (PBS-T), blocked with 5 % nor-
mal donkey serum in PBS-T, and incubated overnight at 4 °C
with antibodies described in Table 1, diluted in 1 % normal
donkey serum (Sigma-Aldrich) in PBS-T. Afterward, the
slices were rinsed with PBS-T and labeled for 1 h at room
temperature with the respective secondary antibodies conju-
gated to Alexa Fluor dyes diluted 1:500 in 1 % donkey normal
serum in PBS-T. After several washes with PBS-T, the slices
were mounted on glass slides, air-dried, and sealed with
Vectashield with Hoechst 33342 Mounting Medium (Vector
Laboratories, Peterborough, UK). Results of c-Fos IF (Fig. 1c)
were obtained from two independent slice cultures (eight an-
imals). Slices from each animal were exposed to all types of
treatment. At least two slices per animal per condition were
analyzed. Results of P-S6 IF (Fig. 1d) were obtained from two
independent slice cultures (three slices/condition/preparation
were analyzed).
Terminal Deoxynucleotidyl Transferase dUTP Nick End
Labeling Assay
The terminal deoxynucleotidyl transferase dUTP nick end la-
beling (TUNEL) assay was performed using the In Situ Cell
Death Detection Kit, TMR red (Roche Applied Science,
Mannheim, Germany). Organotypic hippocampal slices were
permeabilized for 2 min on ice with permeabilization solution
(0.1 % Triton X-100 and 1 % sodium citrate) and incubated
with labeling solution plus enzyme solution at 37 °C for 1 h.
As a negative control, the enzyme solution was omitted. The
slices were then washed three times with PBS-T and counter-
stained with Hoechst 33342 dye and anti-GFAP antibody as
described above. TUNEL staining was performed on two in-
dependent slice cultures (eight animals). Slices from each an-
imal were exposed to all types of treatment. At least two slices
per animal per condition were analyzed.
Confocal Imaging and Analysis
Images of immunofluorescently or TUNEL-stained neurons
were acquired using confocal microscopy. Confocal images
were obtained with sequential acquisition settings at
Fig. 1 In vitro model system to study molecular and cellular responses to
kainic acid. a Scheme of rat organotypic hippocampal slice treatments
with kainic acid (KA) and rapamycin (R). b Expression of c-Fos mRNA
after KA treatment analyzed by qRT-PCR. C control, R rapamycin, KA
kainic acid, KA+R kainic acid+rapamycin. Number of cultures (N) = 3,
number of slices per condition per culture = 4. c Representative confocal
images of CA1/CA3 area of organotypic hippocampal slices
immunofluorescently stained for c-Fos (green) after KA at the indicated
time points. Nuclei were counterstained with Hoechst 33342 (blue). Scale
bar= 50 μm. d Representative confocal images of CA1/CA3 area of
organotypic hippocampal slice TUNEL staining (red) 24 h after
indicated treatment. Slices were additionally immunofluorescently
stained with the glial marker GFAP (green) and counterstained with
nuclear dye Hoechst 33342 (blue). Scale bar= 20 μm. e Representative
confocal images of CA1/CA3 area of organotypic hippocampal slice
TUNEL staining (red) 24 h after indicated treatment. Slices were
additionally immunofluorescently stained with the neuronal marker
MAP2 (green) and counterstained with nuclear dye Hoechst 33342
(blue). Scale bar = 20 μm. f Representative images of organotypic
hippocampal slice with Timm’s staining treated as indicated. Scale
bar= 500 μm (color figure online)
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1024×1024 pixel resolution using a Zeiss LSM 5 Exciter
microscope equipped with Ar (488 and 514 nm), HeNe (543
and 633 nm), and diode (405 nm) lasers. The laser power and
image acquisition settings were kept constant. Each image
was a z-series of images, each averaged twice. The obtained
stack was “flattened” into a single image using maximum
projection.
Morphometric analysis of axon and dendrite length, the
number ends of axons and dendrites, and density, width
and length of dendritic protrusions (spines and filopodia)
of neurons in dissociated in vitro cultures was performed
using MetaMorph image analysis software (Universal
Imaging Corporation, Downingtown, PA, USA). For the
total axon length and axonal ends, the full axonal tree of
each neuron was traced on images acquired at a ×10 ob-
jective (0.6 digital zoom). The number of dendrites and
dendrite length were quantified on images that were ac-
quired with a ×40 objective (0.7 digital zoom) as de-
scribed previously [23]. Quantification of the density,
width, and length of dendritic protrusions was performed
on images acquired with a ×40 objective (×5 digital
zoom). The density of protrusions was counted as the
number of protrusions on the 10 μm dendrite and three
dendritic segments of one neuron. The average length,
protrusion width, and density per cell for each cell were
calculated and used for further averaging. Twenty ran-
domly chosen cells were examined for each experimental
condition for each culture batch. Data were obtained from
three (analysis of axons or dendrites) or two (analysis of
dendritic protrusions) independent batches of neurons. For
further classification of protrusions, the protrusions were
divided arbitrarily into two classes: filopodia (head
width ≤ 0.4 μm) and spines (head width > 0.4 μm). The
densities of filopodia and spines were next calculated as
their number on the 10 μm of dendrite and expressed as
percentage of all counted protrusions. Comparison of the
protrusions length/width ratio were done as described by
Cymerman et al. [32], and data are presented as % cumu-
lative change.
Tissue Collection, RNA Preparation, and Gene
Expression Profiling
To isolate RNA from organotypic hippocampal slices, at the
end of the experiments, slices were placed in RNAlater re-
agent (Life Technology) and stored at −80 °C until use.
RNA was isolated using the RNeasy Mini Kit (Qiagen,
Venlo, The Netherlands) according to the manufacturer’s pro-
tocol. The total RNA concentration was measured using a
NanoDrop Spectrometer 2000 (Thermo Fisher Scientific,
Waltham, MA, USA), and its quality was determined by
chip-based capillary electrophoresis using an RNA 6000
Nano LabChip Kit and Agilent Bioanalyzer 2100 (Agilent,
Palo Alto, CA, USA) according to the manufacturer’s instruc-
tions. RNA from three independent biological repeats was
pooled to create a sample for each microarray (e.g., single
Fig. 2 Kainic acid induces mTOR activity and cell death in organotypic
hippocampal slices. aWestern blot analysis of phosphorylated ribosomal
protein S6 (P-S6; Ser235/236), mTOR, caspase-3, and cleaved caspase-3
in protein lysates obtained from organotypic slices treated as indicated.α-
Tubulin is shown as a loading control. C control, R rapamycin, KA kainic
acid, KA+R kainic acid+rapamycin. b Representative confocal images of
CA1/CA3 area of organotypic hippocampal slice immunofluorescently
stained for P-S6 2 h after R, KA, or KA+R treatment. Scale bar = 50 μm
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sample from one biological repeat that consisted of eight
slices, each from different newborn rats of the same litter). A
starting amount of 800 ng high-quality (RNA integrity num-
bers 9.8–9.9) total RNA (equally pooled from three indepen-
dent experiments) was used to generate cDNA and comple-
mentary RNA (cRNA) with the Illumina TotalPrep RNA
Amplification Kit (Illumina, San Diego, CA, USA). The ob-
tained cDNA served as a template for in vitro transcription
with T7 RNA polymerase and biotin UTP to generate multiple
copies of biotinylated cRNA. Each cRNA sample (1.5 μg)
was hybridized overnight to a RatRef-12 BeadChip array
(Illumina). The chips were then washed, dried, and scanned
with the BeadArray Reader (Illumina). Three biological rep-
licates were used per time point and 12 arrays per each treat-
ment group; the number of control samples was doubled. The
treatment group samples were equally distributed between
array plates and hybridization batches. Raw microarray data
were generated using BeadStudio 3.0 (Illumina).
Microarray Data Analysis
Microarray quality control was performed using the
BeadArray R package. The following parameters were
checked on all 60 arrays: number of outliers, number of beads,
and percentage of detected probes. After background subtrac-
tion, the data were normalized using quantile normalization
and then log2-transformed. The obtained signal was taken as
the measure of mRNA abundance derived from the level of
gene expression. Statistical analysis of the results was per-
formed using two-way analysis of variance (ANOVA), with
KA and time as factors, followed by Benjamini and Hochberg
correction for multiple testing (percent FDR; [33]). The effects
of rapamycin on KA-induced alterations in gene expression
are presented as differences in fold changes. All of the statis-
tical analyses were performed using R software [34].
Hierarchical clustering was performed with dChip software
using the Euclidean distance and average linkage method.
The functional annotation analysis tool DAVID 2008 was
used to identify overrepresented ontologic groups among the
gene expression patterns and group genes into functional clas-
sifications [35]. The identification of overrepresented tran-
scription factor binding sites (TFBSs) was performed using
the cREMaG database with default parameters [36].
Reverse-Transcription Quantitative Real-Time
Polymerase Chain Reaction
RNA from organotypic hippocampal slices, hippocampi or
cultured neurons was isolated with the RNeasy Protect Mini
Kit (Qiagen). cDNA was prepared with High Capacity
RNA-to-cDNA Master Mix (Life Technologies) according
to the manufacturer’s protocol. qRT-PCR was performed with
a 7900HT machine and TaqMan Array Fast Plates (Life
Technologies) with the following TaqMan rat probes: Tubb6
(Rn01253666_m1), Bdnf (Rn01484924_m1), Elmo1
(Rn01528402_m1), Lrrfip2 (Rn01245379_m1), Npas4
(Rn00596522_m1), Nr4a3 (Rn00581189_m1), Abra
(Rn00598518_m1), Adrb1 (Rn00824536_s1), Cdr2
(Rn01511457_m1), Vgf (Rn00578591_g1), Gprc5a
(Rn01459296_m1), Gadd45g (Rn01435432_g1), Nfil3
(Rn01434874_s1), Scg2 (Rn01400686_g1), Egr4
(Rn00569509_g1), and c-Fos (Rn02396759_m1). Actb
(Rn00667869_m1) or Gapdh (Rn99999916_s1) was used as
an internal control. SDS 2.4 and RQ Manager 1.2.1 programs
were used for data acquisition and preliminary analysis.
Preparation of Protein Extracts and Western Blot
Analysis
For the biochemical studies, organotypic hippocampal
slices or cortical cultures were collected and stored at
−80 °C until use. Cortical cultures were lysed in SDS sam-
ple buffer. To extract proteins from slices, the slices were
lysed in homogenization buffer (10 mM Tris, pH 7.6,
1 5 0 mM NaC l , 2 mM EDTA , a n d 0 . 3 % 3 -
[ ( 3 - c h o l am i d o p r o p y l ) d i m e t h y l ammo n i o ] - 1 -
propanesulfonate [CHAPS]) supplemented with protease
(Roche, Indianapolis, IN, USA) and phosphatase inhibitors
(Sigma-Aldrich) and centrifuged at 14,000×g for 30 min at
4 °C. The supernatants were collected, and the protein con-
centration in the obtained protein lysates was measured
using the DC Protein Assay (Bio-Rad Laboratories,
Hercules, CA, USA). The proteins from both types of ex-
periments were then analyzed by Western blot. After pro-
tein electrotransfer, the membranes were blocked for 1 h at
room temperature in 5 % nonfat dry milk in TBS-T
(Tris-buffer saline, pH 7.6, with 0.1 % Tween 20) and in-
cubated overnight at 4 °C with primary antibodies (see
Table 1). For enhanced chemiluminescent detection
(ECL), the next day, the membranes were washed several
times with TBS-T and incubated for 1 h with horseradish
peroxidase (HRP)-conjugated secondary antibodies diluted
in TBS-T that contained 5 % nonfat dry milk (see Table 1).
Finally, the membranes were washed with TBS-T, incubat-
ed for 1 min with ECL reagent, and immediately exposed to
X-ray film (Sigma-Aldrich). Western blot analysis of levels
of phosphorylated ribosomal protein S6 (P-S6; Ser235/236),
mTOR, caspase-3, and cleaved caspase-3 in organotypic
slices (Fig. 2a) was performed on protein lysates obtained
from three independent slice culture preparations (eight
slices/condition/culture). The quantification of Western blot
bands (Fig. 4) was performed using MetaMorph image anal-
ysis software (Universal Imaging Corporation, Downingtown,
PA, USA). Bands that corresponded to Elmo1 and α-tubulin
were manually traced, and their average area was automatical-
ly determined. The results are presented as the ratio of the
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average area of the Elmo1 band to the average area of the
α-tubulin band.
Timm’s Sulfate Silver Staining
To visualize aberrant axonal sprouting, Timm staining was
used [37]. Slices still placed in culture inserts, were incubated
for 10 min with 1 % sodium sulfide in 0.1 M phosphate buffer
(PB), followed by the gentle addition of 0.3 % glutaraldehyde
in PB [37] and incubation for another 5 min. The slices were
then washed with PB and postfixed overnight at 4 °C with
70 % ethanol. The next day, the preparations were washed
again with PB and incubated with development solution
(50 % gum arabic solution, 0.5 M hydroquinone solution,
1.2 M citric acid, 0.8 M trisodium citrate, and 0.37 M silver
lactate) for 30 min in the dark. After this step, the slices were
washed with water, and Timm staining was fixed with 5 %
thiosulfate for 12 min, followed by washing with water. The
slices were then incubated with 70 % ethanol for 30 min,
placed on gelatin-coated glass slides, dehydrated, cleared,
and coverslipped. Timm’s staining was performed on two in-
dependent slice cultures (eight animals). Two to four slices per
condition were analyzed.
Statistical Analysis
The data were obtained from at least three batches of
pooled slices or cultured cells. The results were analyzed
using Prism software (GraphPad, La Jolla, CA, USA). For
qRT-PCR analysis of c-fos expression and validation of
microarray data, performed in slices and in vivo, we used
Kruskal-Wallis test without following multiple compari-
sons tests due to low n of observations. For comparison
of qRT-PCR and Western blot results obtained with use of
cortical neurons, we used one-way ANOVA followed by
Sidak’s multiple comparisons test. The Mann–Whitney
test was used for the statistical analysis when two groups
were compared. The statistical analysis of the microarrays
was described in relevant section above.
Results
Neuronal Responses to Kainic Acid Are Mimicked
in Hippocampal Organotypic Slices
A previous study indicated that KA-induced status epilep-
ticus results in substantial changes in the transcriptome
[38] and increases mTOR activity in adult animals [11].
Although mTOR regulates transcription [16], this specific
aspect has not been previously studied in the context of
proconvulsive drug actions. Thus, we investigated the ef-
fects of rapamycin on KA-induced changes in the
transcriptome. We first established a simplified in vitro
culture model that allowed the reduction of heterogeneity
of animal responses to KA and excluded the necessity for
prolonged and repetitive rapamycin injections. We used
DIV5 organotypic hippocampal slices from newborn rats
and tested their responses to KA and mTOR inhibition
(Figs. 1 and 2). These preparations, similar to intact ani-
mals, responded to KA with robust and transient expres-
sion of c-Fos, an immediate early gene, at the mRNA and
protein levels (Fig. 1b, c). c-Fos mRNA and protein ex-
p re s s ion reached a max imum at 2 h pos t -KA
(Kruskal-Wallis test with no post hoc test due to low n
of observations, p< 0.01 for 2 and 6 h) and returned to
control levels at 24 h. We also tested our preparations for
cell death, astrogliosis, and the sprouting of mossy fibers
(i.e., long-term changes that are typically evoked by KA
in vivo; [39]. Both TUNEL staining and the analysis of
caspase-3 cleavage confirmed enhanced cell death in
slices upon KA treatment (Figs. 1d and 2a). The immu-
nofluorescent GFAP and MAP2 staining of slices con-
firmed that KA primarily affected survival of cells posi-
tive for MAP2 but not GFAP (Fig. 1d, e). GFAP immu-
nostaining also revealed astrogliosis. Neuronal death that
is induced by KA in the CA3 region of the hippocampus
induces granule cells in the dentate gyrus to search for
new synaptic targets, usually dendrites of other DG sur-
vivors. The formation of such aberrant connections, called
aberrant sprouting, is a hallmark of epileptogenesis [40].
Timm’s sulfate silver staining revealed that KA that was
added to organotypic hippocampal cultures induced
mossy fiber sprouting 16 days post-KA. Consistent with
previous in vivo results [11], rapamycin prevented this
anatomical rearrangement (Fig. 1e). We next evaluated
whether KA induces mTORC1 activity by monitoring
Fig. 3 Hierarchical clustering of transcriptional alterations in response to
KA in rat hippocampal slices and validation of selected gene expression
changes. a Microarray results are shown as a heat map and include rat
genes with genome-wide significance (two-way ANOVA of KA effects;
FDR< 1 %). Colored rectangles represent transcript abundance of the
genes labeled on the right. Gene expression was measured 0.5, 2, 6, and
24 h after KA, rapamycin (R), or KA+R treatments. The experimental
groups are indicated above the heat map. The intensity of the color is
proportional to the standardized values (between −3 and 3) from each
microarray as indicated on the bar below the map image. Clustering
was performed using Euclidean distance according to the scale on the
left. KA-regulated genes were segregated into five time-dependent gene
clusters (A–E). b Results of qRT-PCR-based analysis of indicated gene
expression in organotypic hippocampal slices treated as indicated. The
data are presented as mRNA fold changes relative to the control
± standard error (number of cultures [N] = 3; number of slices per
culture: C, n= 16; R, n= 8; KA, n = 8; KA+R, n= 8. c Results of qRT-
PCR-based analysis of indicated gene expression in hippocampi of rats
treated as described in [11]. The data are presented as mRNA fold
changes relative to the control ± standard error (number of animals: C,
n= 3; R, n= 5; KA, n= 3; KA+R, n= 5)
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the phosphorylation of ribosomal protein S6 (P-S6) at Ser
235/236. Similar to previously published results in intact
animals [11], KA increased the level of P-S6 in a
rapamycin-dependent manner (Fig. 2a, b). These results
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indicate that processes typically triggered by KA in vivo,
like c-Fos expression and mTOR pathway induction, cell
death, astrogliosis, and axonal sprouting can be also in-
duced in organotypic hippocampal slices in response to
KA.
Gene Expression Profiling of Kainic Acid-
and Rapamycin-Induced Transcriptional Changes
Genomic research strategies have recently transitioned from
the search for unknown genes to the identification and evalu-
ation of coordinated gene networks and transcriptional signa-
tures. Thus, to identify the potential contribution of mTOR to
KA-evoked changes in the transcriptome, we used Illumina
whole-genome rat microarrays to analyze the time course of
gene expression alterations following KA administration in
the presence or absence of rapamycin. To analyze the dynam-
ics of early, intermediate, and relatively late changes inmRNA
abundance, the analysis was performed 0.5, 2, 6, and 24 h
after drug administration (Fig. 1a). We identified 81
KA-responsive genes (two-way ANOVA, FDR<1 %), which
were divided into five major clusters (A–E; Fig. 3a,
Supplementary Table 1, Online Resource 1). The clusters re-
vealed diverse KA-induced and time-dependent patterns of
upregulation (clusters B–E) and downregulation (cluster A)
of gene expression. Assuming the coordinated transcriptional
regulation of identified genes, we searched for the overrepre-
sentation of transcription factor binding sites. We found the
overrepresentation of transcription factor binding sites, for
such transcription factors as SRF (e.g., Egr1, Egr2, and
Npas4) and CREB1 (e.g., Ier2, Dusp1, and Fos) in the pro-
moter regions of the regulated genes (TFBS fold>4; p<0.05).
As we expected, expression of the majority of these genes,
present mostly in cluster D, was previously reported as depen-
dent on neuronal activity. We also identified few genes regu-
lated by rapamycin alone, including Sphk1, Penk1, and
LOC304131 (two-way ANOVA, FDR<1 %; Supplementary
Table 2 [Online Resource 2] and Supplementary Fig. 1
[Online Resource 3]). Rapamycin induced alterations in the
KA-induced expression of genes from cluster C (0.5 h time
point according to scheme of experiment), cluster B (0.5 h
time point), and cluster E (2 h time point) (Supplementary
Table 1, Online Resource 1). Specifically, these effects, al-
though weak, were visible as the enhanced induction of sev-
eral genes from cluster B at the 2 h time point and inhibition of
the expression of genes from clusters C and E at 2, 6, or 24 h
(Supplementary Table 1, Online Resource 1 and
Supplementary Fig. 2, Online Resource 3). Based on this ev-
idence, we concluded that mTORC1 inhibition has discrete
rather than global impact on KA-evoked transcriptome
changes.
Effects of mTORC1 Inhibition on Kainic Acid-Induced
Expression of Selected Genes
Although global analysis of the microarray data did not
point to a group of genes with common characteristics
that are regulated by mTORC1 in response to KA, of
the list of genes that were differentially expressed be-
tween the KA and rapamycin+KA groups, we selected
candidate genes, expression of which was downregulated
by rapamycin (Supplementary Fig. 2, Online Resource 3),
for further validation. We validated microarray results by
qRT-PCR using total RNA that was isolated from
organotypic hippocampal slices (mRNA aliquots were
collected in parallel for both analyses). Detailed
Fig. 4 Kainic acid-induced Elmo1 expression is mTOR-dependent in
cultured cortical neurons. a Results of qRT-PCR-based analysis of
Elmo1 expression in cortical neurons cultured in vitro for 5 days and
treated as indicated (C control, R rapamycin, KA kainic acid, KA+R
KA+rapamycin). The data are presented as mRNA fold changes
relative to the control ± standard error (number of cultures N = 5).
Significant differences in transcript abundance between the treatments
and controls are indicated by asterisks (***p < 0.001). Significant
differences in transcript abundance between KA and KA+sR are
indicated by hash signs (###p < 0.001; one-way ANOVA followed by
Sidak’s multiple comparisons test). b Representative result of Western
blot analysis of Elmo1 expression in cortical neurons cultured in vitro
for 14 days and treated as indicated. c Quantitative analysis of Western
blot of Elmo1 expression levels in cortical neurons cultured in vitro for
14 days and treated as indicated (number of cultures N= 5). α-Tubulin
levels were used for normalization. Significant differences in protein
abundance between the treatments and controls are indicated by
asterisks (*p < 0.05). Significant differences in protein abundance
between KA and KA+R are indicated by hash signs (#p < 0.05; one-
way ANOVA followed by Sidak’s multiple comparisons test)
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Fig. 5 Elmo1 overexpression in hippocampal neurons affects axonal
growth and dendritic spine morphology and density. a Representative
confocal images of hippocampal neurons transfected on DIV1 with a
plasmid that encoded GFP or Elmo1-GFP and fixed 3 days later. β-
Actin-tdTomato was cotransfected to highlight transfected cell
morphology. b Number of axonal ends and c axonal length of cells
transfected as in a. *p < 0.05, **p < 0.01 (Mann–Whitney test). Cell
images were obtained from three independent culture batches. Number
of cells (n): GFP, n = 70; Elmo1-GFP, n = 58. Scale bar = 100 μm. d
Representative confocal images of hippocampal neurons transfected on
DIV8 with a plasmid that encoded GFP or Elmo1-GFP and fixed 3 days
later. β-Actin-tdTomato was cotransfected to highlight transfected cell
morphology. e Number of dendritic ends and f total dendrite length of
cells transfected as in d. ns nonsignificant (Mann–Whitney test). Cell
images were obtained from three independent culture batches. Number
of cells (n): GFP, n = 58; Elmo1-GFP, n = 55. Scale bar = 20 μm. g
Representative confocal images of dendrite segments of hippocampal
neurons transfected on DIV18 with a plasmid that encoded GFP or
Elmo1-GFP and fixed 3 days later. β-Actin-tdTomato was cotransfected
to highlight transfected cell morphology. h Average protrusion density, i
protrusion width, and j protrusion length per cell of cells transfected as in
g. kCumulative distribution of protrusion length to width ratio of neurons
transfected as in g. l, m Contribution of spine and filopodia to the cell
protrusion population of transfected cells. ns nonsignificant. **p< 0.01
(Mann–Whitney test). Number of independent cultures N= 2. Number of
cells (n): GFP, n= 39; Elmo1-GFP, n = 36. Scale bar= 10 μm
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inspection of the microarray results revealed several
genes, the levels of which differed between the KA and
rapamycin+KA groups (e.g., Tubb6, Bdnf, Elmo1, Lrrfip2,
Npas4, Nr4a3, Abra, Cdr2, Vgf, Gprc5a, Nfil3, Scg2, and
Egr4 [all from cluster E] and Gadd45g [cluster C];
Fig. 3a; Supplementary Table 1, Online Resource 1).
The expression patterns of the majority of the analyzed
genes were consistent with those that were revealed by the
microarray analysis (Fig. 3b, Supplementary Fig. 3
[Online Resource 3]). We observed the impact of
rapamycin on the effects of KA for Elmo1, Abra,
Gprc5a, Nr4a3, Vgf, Tubb6, Gadd45g, and Npas4. In
many cases, qRT-PCR is more sensitive than microarrays.
Therefore, the effects of rapamycin were detected at ad-
ditional time points (Fig. 3b, Supplementary Fig. 3A
[Online Resource 3]). In the case of Elmo1, Abra,
Gprc5a, Nr4a3, Vgf, Tubb6, and Gadd45g, we noted an
impact of rapamycin on their KA-induced expression also
at earlier time points. To further validate our observations,
we analyzed by qRT-PCR expression of selected genes in
hippocampi of rats 2 h post-KA. As shown in Fig. 3c and
Supplementary Fig. 3B (Online Resource 3), expression
of Elmo1, Abra, Gprc5a, Nr4a3, Vgf, Npas4, Tubb6, and
Gadd45g substantially increased compared to control rats.
At the same time, long-term rapamycin pretreatment
(4 weeks; see [11] for detailed description of experiment
and validation of rapamycin effectiveness as mRNA was
obtained in course of experiments described there) con-
siderably decreased KA-induced increases of Elmo1,
Abra, Gprc5a, Vgf, and Gadd45g mRNA levels. Thus,
we concluded that KA-induced mTORC1-dependent
changes in the selected gene expression, identified by mi-
croarray approach, indeed occur, both in hippocampal
slices cultured in vitro as well as in the brain in vivo.
Long-Lasting Increase in Elmo1 Expression Affects
Neuronal Morphology
We next focused on Elmo1 (cluster E) because its upreg-
ulation by KA was long-lasting and efficiently blocked by
rapamycin at 6 and 24 h. What is more, Elmo1 was de-
scribed to regulate actin cytoskeleton during neuronal de-
velopment [26, 41]. To verify that KA-triggered changes
in Elmo1 expression translate into alterations at the pro-
tein level, we produced a new anti-Elmo1 antibody be-
cause none of those that are commercially available met
our specificity criteria (e.g., all tested antibodies recog-
nized several bands, none of which was affected by
RNA interference; not shown). This newly generated an-
tibody, which targets the C-terminus of Elmo1, recognizes
overexpressed and endogenous proteins of proper size in
cultured cortical neurons that are electroporated with
β-actin-Elmo1-GFP (Supplementary Fig. 4, Online
Resource 3). Moreover, the signal that corresponded to
the endogenous signal weakened upon the transfection
of neurons with a plasmid that encoded shRNA against
Elmo1 mRNA (Supplementary Fig. 4, Online Resource
3). Using this antibody, we sought to confirm the increase
in Elmo1 protein in response to KA in our slice prepara-
tions. However, because of the low amount of protein, we
did not obtain statistically significant confirmation.
Therefore, to ensure a sufficient amount of material for
the biochemical analysis, we switched to in vitro cultured
cortical neurons. We first confirmed that KA treatment in
these cel ls increased Elmo1 mRNA levels in a
rapamycin-dependent manner. As shown in Fig. 4a,
Elmo1 expression increased 4 h post-KA and rapamycin
significantly prevented the effects of KA on Elmo1
mRNA levels. Similar results were found for Elmo1 pro-
tein levels (Fig. 4b, c). Decrease of P-S6 levels addition-
ally confirmed that rapamycin efficiently silenced mTOR
signaling at the tested time points (Fig. 4b).
Elmo1 is known to regulate F-actin dynamics, which
underlies physiological and pathological rearrangements
of neuronal morphology during development [26, 41].
Thus, we evaluated effects of the prolonged elevated ex-
pression of Elmo1 on the morphology of hippocampal
neurons cultured in vitro at different developmental
stages. Specifically, we morphometrically analyzed axo-
nal and dendritic arbors of developing neurons and den-
dritic protrusions (spines and filopodia) of mature ones.
Changes in axonal arborization and the number and
shape of dendritic protrusions were previously reported
in aberrant neuronal plasticity that accompanies
epileptogenesis. We cotransfected cultured neurons for
3 days with β-actin-Elmo1-GFP and β-actin-tdTomato
(to highlight the morphology of transfected neurons)
and analyzed their morphology. We used DIV1, −7 de-
veloping, and −18 mature neurons for the analysis of
axons, dendrites, and dendritic protrusions, respectively.
As shown in Fig. 5a–c, axon length and number of ax-
onal ends significantly increased upon Elmo1-GFP over-
expression. In contrast, increases in the levels of Elmo1
did not affect either number of dendritic tips or total
dendritic length (Fig. 5d–f). In case of dendritic protru-
sions the morphometric analysis revealed that cells that
were transfected with β-actin-Elmo1-GFP had a lower
density of dendritic protrusions compared with controls,
which were also in average significantly longer (Fig. 5g–
i). We also observed, tendency for dendritic protrusions
width decrease in Elmo1 overexpressing neurons, which
did not however reach statistical significance (Fig. 5j).
Analysis of length to width ratio [32] indeed confirmed
substantial shift of protrusion morphology toward
filopodia-like one (Fig. 5k). Indeed, close inspection of
specific frequencies of filopodia and spines in Elmo1
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overexpressing cells revealed significant increase and de-
crease in filopodia and spine numbers, respectively
(Fig. 5l, m). This suggests that Elmo1 overexpression
in mature neurons, as oppose to developing ones [26]
leads to spine destabilization and elimination.
Discussion
mTOR inhibition has been considered for antiepileptogenic
therapy [42, 43]. Epileptogenesis has been established to be
associated with long-term changes in gene expression. We
used a simplified in vitro culture system to investigate whether
rapamycin affects transcriptome changes that are evoked by
KA. We found that processes typically triggered by KA
in vivo, like c-Fos expression and mTOR pathway induction,
cell death, astrogliosis, and axonal sprouting were also in-
duced in organotypic hippocampal slices in response to KA.
The microarray analysis revealed changes in the transcription
profiles of several genes in response to KA. Rapamycin af-
fected only some of those changes, for example by preventing
Elmo1, Abra, Gprc5a, Nr4a3, Vgf, Tubb6, Gadd45g, and
Npas4 expression upregulation, suggesting that mTORC1 is
not massively affecting KA-evoked transcriptome changes.
We further focused on Elmo1, a modulator of actin dynamics
and found that Elmo1 overexpression in hippocampal neurons
increased axonal arborization and decreased dendritic spine
density.
Effects of Kainic Acid on Organotypic Cultures
in the Context of In Vivo Data
In this work, we described a simplified in vitro model to study
molecular changes that are induced by KA. Importantly, we
showed that the essential hallmarks of in vivo epileptogenesis
(e.g., the induction of c-Fos expression, astrogliosis, neuronal
death, and aberrant axonal sprouting) were reproduced in
organotypic hippocampal slices in response to KA. One issue
that arose was the extent to which our gene profiling results
are consistent with data from in vivo models. Multiple gene
profiling studies have been conducted using animal models of
epilepsy [44]. Differentially expressed genes have been re-
ported in status epilepticus or poststatus epilepticus rodent
models, e.g. application of KA [45, 46] and pilocarpine [47,
48], or electrical stimulation [49, 50]. Notably, despite the
large amount of data that have already accumulated, a com-
parative meta-analysis is difficult to perform because of the
different experimental designs and microarray platforms that
have been used in previous studies. Our data overlap to a
largest extent with those of Kuzniewska et al. [46], who per-
formed gene profiling in response to intrahippocampus-
administered KA. Among the overlapping genes were
Elmo1, Gadd45g, Npas4, Egr4, Gprc5a, Scg2, Nr4a3, Egr1,
and Zfp36. Also, other genes identified by us were previously
reported in animal models of epilepsy, including c-Fos and
c-Jun [51], Bdnf [52], Dusp1 [53], Arc [54], Penk1 [55–57],
Egr2 [58], Crem [59], and Id1 [60, 61]. Thus, we conclude
that our simplified model recapitulates major molecular and
cellular changes that are observed in in vivo models of epilep-
sy. Consistently, several genes, expression of which was in-
duced by KA in rapamycin-dependent manner in organotypic
hippocampal cultures were controlled in similar way in vivo
(Fig. 3c).
Effects of Rapamycin on Kainic Acid-Induced Gene
Expression
Several recent reports suggest that the mTOR pathway may be
central to epileptogenesis and therefore could be a convenient
therapeutic target [14, 62]. Rapamycin has antiepileptogenic
effects (e.g. prevents aberrant mossy fiber sprouting, appear-
ance of recurrent seizures) in models of epilepsy in animals
[12–15]. In the present study, we focused on the influence of
rapamycin on mRNA expression profiles under basal condi-
tions and in response to KA. Our major observation was that
rapamycin influences the expression of a small subset of genes
induced by KA, rather than globally counteracts changes in-
duced in transcriptome by KA. This is consistent with multi-
ple actions of rapamycin including decrease in protein synthe-
sis and induction of autophagy, which both may contribute to
epileptogenesis prevention [63, 64]. Still it raises a question,
what is the molecular mechanism that underlies the effects of
rapamycin on KA-driven gene expression and provides ob-
served selectivity of rapamycin effects. Because gene profil-
ing only reveals the amount of a transcript, one should con-
sider the role of mTOR in either the regulation of transcription
or mRNA stabilization. In nonneuronal cells, mTOR is known
to regulate activity, cellular localization, and the level of sev-
eral transcription factors [16], e.g., hypoxia-inducible factor
1α (HIF-1α), increased expression of which was reported in
animal models of epilepsy [65, 66]. However, in our analysis,
we did not identify TFBS for HIF-1α in promoters of
KA-upregulated genes that were affected by rapamycin.
However, several rapamycin-modulated genes (e.g., Elmo1,
Gadd45g, and Npas4) were also identified in a recent tran-
scriptome study by Kuzniewska et al. [46], as controlled by
SRF in response to KA. Additionally, chronic rapamycin
treatment in rats and SRF knockout in the mouse forebrain
increased the susceptibility to seizures and their severity [11,
46]. One issue is the way in which mTOR influences SRF
transcriptional activity. Although no potential mechanism
has been described to date, the present results identified
Abra (STARS) as a rapamycin-modulated gene. The Abra
product activates SRF-dependent transcription, inducing the
nuclear translocation of megakaryoblastic leukemia 1
(MKL1) or MKL2 [67]. Thus, rapamycin could theoretically
Mol Neurobiol
specifically downregulate SRF-dependent transcription to reg-
ulate the cellular localization of MKLs.
An alternative explanation for the contribution of mTOR to
KA-induced gene expression is its involvement in transcript
stabilization. mTOR participates in this process in
nonneuronal cells. For example, rapamycin decreases the
steady-state level of collagen (COL1A1 and COL1A2)
mRNA in fibroblasts and destabilizes inducible nitric oxide
synthase mRNA in astrocytes and transient receptor potential
melastatin 6 in renal tubular epithelial cells [68–70]. Whether
mTOR stabilizes transcripts that are induced by status epilep-
ticus remains to be investigated.
Potential Contribution to Kainic Acid-Related
Neuropathology at the Cellular Level
Our data suggest that mTOR inhibition modulates the
KA-induced expression of a subset of genes, but unknown is
whether it has a potential impact on epileptogenesis. Knowing
their cellular functions, we hypothesize that rapamycin could
modulate cell death and cytoskeleton rearrangements, which
both contribute to epileptogenesis. For example, Gadd45g
plays a role in neuronal apoptosis during KA-dependent status
epilepticus [71].Moreover, Abra [72, 73], Elmo1 [74, 75], and
Nr4a3 [76] were previously implicated in apoptosis. In our
model, however, we could not prove antiapoptotic effects of
rapamycin (see Fig. 2 for lack of an effect of rapamycin on
KA-induced cleavage of caspase-3). Therefore, one possibili-
ty is that rapamycin, although it affects the expression of po-
tentially proapoptotic genes, is unable to prevent the first wave
of excitotoxic cell death upon KA application. Among our
candidates, the products of three genes (Tubb6, Abra, and
Elmo1) are known to modulate the cytoskeleton. Tubb6 en-
codes β-tubulin, and dynamic microtubules contribute to ax-
onal growth and spine shape changes [30, 77, 78].
Nonetheless, the particular functions of this β-tubulin isoform
in the nervous system have not been described but its deletion
may contribute to microcephaly (Jawad syndrome; [79]).
Abra increases the actin polymerization of muscle cells [67],
but its role in neurons has not been described. In theory, its
lowered expression in response to rapamycin could prevent
KA-induced neuronal changes in dendritic spine morphology
or mossy fiber sprouting. Elmo1 is also a regulator of RhoA
and Rac1. Via these small GTPases, it regulates actin dynam-
ics. The potential contribution of Elmo1 to KA-induced
changes is discussed below.
Potential Contribution of mTOR-Dependent Elmo1
Regulation to Pathology
In the present study, we identified Elmo1 as a gene whose
expression is activated byKA and is modulated by rapamycin.
Using cortical neuron cultures in vitro, we also demonstrated
that changes in the amount of Elmo1 mRNA correlate well
with changes in Elmo1 protein levels. Elmo1 is a regulator of
RhoA and Rac1 and via these small GTPases Elmo1 regulates
actin cytoskeleton. Elmo1 was shown to participate in neuro-
nal apoptosis and neurite outgrowth [80]. Thus, in our in vitro
model, the KA-induced expression of Elmo1 would be asso-
ciated with reorganization of the cytoskeleton. Consequently,
the downregulation of Elmo1 expression could explain the
effects of rapamycin on KA-induced neuronal morphological
changes, such as axon sprouting and spine shape rearrange-
ments, which depend on the actin cytoskeleton. In the present
study, we investigated effects of increased Elmo1 expression
on morphology of developing and mature hippocampal neu-
rons cultured in vitro. In case of developing cells, we reported
that overexpression of Elmo1 induces axonal growth and ar-
borization. This result corroborates potential role of Elmo1 in
epilepsy-related sprouting but does not prove it because
epilepsy-related sprouting occurs in mature cells.
Unfortunately, for technical reasons, it was impossible to un-
doubtedly trace axons of mature neurons in our type of cul-
ture. Yet, our observation brings new information concerning
Elmo1 and suggests that cellular availability of this protein
may limit axonal growth during development. This result is
somewhat contradictory with work of Franke et al. [41], who
showed that RhoG/Elmo1/Dock180/Rac1 pathway restricts
axonal branching of embryonic hippocampal neurons. Yet,
Franke et al. [41] used mutant Elmo1, which can not bind
Dock180 (Elmo1-D625) but did not study wild type Elmo1.
Thus, one can speculate that Elmo1 possesses progrowth ac-
tivity which is mitigated by Dock180. Alternatively, it is pos-
sible that Elmo1 acts also outside its canonical pathway during
axonal growth, but in such case, the role of Rac1 and actin
cytoskeleton cannot be readily claimed.
Another novel finding reported herein is that increased
Elmo1 level in mature hippocampal neurons resulted in reduc-
tion of dendritic spine number as well as induced their shape
change to filopodia-like one. Thus, increased Elmo1 expres-
sion in mature neurons, a model relevant to developmental
stage for which we performed gene profiling experiments,
seems to drive spine elimination. Notably, decreases in spine
number have been reported in mouse brain 24 h post-KA [81].
It would be of interest to check if rapamycin prevents spine
elimination induced by KA. In addition, our result suggests
that Elmo1 plays different role in developing and mature neu-
rons with regard to dendritic spines since Kim et al. [26],
overexpressed Elmo1 in developing neurons at the advent of
spinogenesis (DIV6) and reported slight increase in number of
dendritic spines by DIV18.
In conclusion, data presented herein show that increased
activity of mTORC1 in response to kainic acid is not affecting
gene expression globally. However, our findings suggest that
rapamycin, in addition to previously described activities, may
indeed affect development of epilepsy, by modulating
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expression of specific subset of genes, including Elmo1 and
point to a potential role for Elmo1 in morphological changes
that accompany epileptogenesis.
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